Membrane environment rather than tissue factor expression determines thrombin formation triggered by monocytic cells undergoing apoptosis.
Monocyte apoptosis is an important determinant of atherothrombosis. Two major mechanisms for apoptosis-associated thrombogenicity have been described: exposure of negatively charged membrane phospholipids and up-regulation of tissue factor (TF). However, the relative importance of these mechanisms is unclear. Thus, procoagulant functions (thrombin generation) of apoptotic (staurosporine, 2 muM, 24 h) U937 cells versus cell-derived microparticles (MPs) were studied. In apoptotic U937 cells, a significant increase in TF mRNA (real-time PCR), surface expression of TF (flow cytometry), and total cellular amount of TF (Western blotting) was observed. Control cells only minimally triggered thrombin generation (endogenous thrombin potential), and apoptotic cells were highly procoagulant. However, addition of negatively charged membranes completely restored the thrombin generation capacity of control U937 cells to the levels of apoptotic cells. MPs (defined as CD45(+) particles of subcellular size), derived from apoptotic U937 cells, were highly procoagulant but did not exhibit an increased TF expression or annexin V binding. Taken together, our data support the concept that the membrane environment, independent of TF expression, determines the extent of thrombin formation triggered by apoptosis of monocytic cells. Externalization of negatively charged phospholipids represents the most important mechanisms for whole cells. Additional yet unknown mechanisms appear to be involved in the procoagulant actions of MPs derived from apoptotic monocytes.
Stampfuss
Jan Julius
JJ
Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Univesität Düsseldorf, Düsseldorf, Germany.
Censarek
Petra
P
Bein
Daniela
D
Schrör
Karsten
K
Grandoch
Maria
M
Naber
Christoph
C
Weber
Artur-Aron
AA
D017209:Apoptosis; D001779:Blood Coagulation Factors / Q000502:physiology; D002462:Cell Membrane / Q000378:metabolism; D006801:Humans; D009000:Monocytes / Q000502:physiology*; D019311:Staurosporine / Q000494:pharmacology; D013917:Thrombin / Q000096:biosynthesis*; D013925:Thromboplastin / Q000235:genetics / Q000502:physiology*; D020298:U937 Cells
D001779:Blood Coagulation Factors; C045071:leukocyte procoagulant activity; D013925:Thromboplastin; D013917:Thrombin; D019311:Staurosporine